Funding · Seed · 30 September 2026

Sonotarg raises £956k

Sonotarg, a healthtech company based in Northern Ireland, issued 9,001 new shares at £106.17 each on 30 September, according to its Companies House filing. That adds up to £956k of new capital. At that share price, the indicative valuation after the round is about £22.4m. Investors have not been named in the filing yet.

✓ Verified · official record, 6 Nov 2026. What this means

£956kNew capital
£106.17Price per share
£22.4mIndicative valuation after the round
17thRound size percentile, 23 seed rounds
4.3%New shares as share of company
Filing-verified
CompanySonotarg
StageSeed
SectorHealthTech
Based inNorthern Ireland
Shares issued9,001 of 211,319 in issue
InvestorsNot named in the filing yet
SourceCompanies House filing · confidence highView source ↗

How we work this out: the amount is the number of new shares multiplied by the price paid for each one, as reported on the SH01 filing. The valuation is that price multiplied by every share in issue afterwards. It's indicative only: it ignores options and convertible notes, some rounds are filed in more than one tranche, and companies can hide it. Methodology

Company record · Companies House
Company numberNI656568 ↗
Incorporated23 October 2018 (8.1 years old)
Accounts filedSmall company (turnover under £15m)
DirectorsDavid Edward Andrews, Timothy John Brundle, James Chorlton, Anthony, Prof Mchale, Ivan Ernest Mcminn, Benjamin Jordan Nutbeam, Mark Alexander Taylor, Nigel Rupert Trim
Secured lendingNone registered
Your note on Sonotarg

Sign in to keep private notes on this company.

If this is your company

Hide the valuation estimate straight away, add your investors, or tell us something's wrong. We check every change.